The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 27, 2019
Filed:
Jul. 25, 2017
Applicant:
Ausio Pharmaceuticals, Llc, Cincinnati, OH (US);
Inventor:
Richard L. Jackson, Cincinnati, OH (US);
Assignee:
AUSIO PHARMACEUTICALS, LLC, Cincinnati, OH (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/353 (2006.01); C12Q 1/26 (2006.01); C12Q 1/48 (2006.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
A61K 31/353 (2013.01); C12Q 1/26 (2013.01); C12Q 1/48 (2013.01); C12Q 1/6883 (2013.01); C12Y 109/03001 (2013.01); C12Y 203/03001 (2013.01); C12Q 2600/118 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/50 (2013.01);
Abstract
The present invention provides a method for diagnosing or determining the risk of developing Alzheimer's disease and for treating Alzheimer's disease with S-equol. An aspect of the present invention includes the use of a direct mitochondrial target engagement biomarker to diagnose or assess the risk of developing Alzheimer's disease. Another aspect of the present invention includes the use of a pharmaceutically effective amount of S-equol to treat or prevent Alzheimer's disease in a subject diagnosed with or determined to be at risk of developing Alzheimer's disease.